-
Rare mountain gorilla twins born in DR Congo: park authorities
-
Ex-midwife enthroned as first female Archbishop of Canterbury
-
AC Schnitzer: When Iconic Tuners Fall Silent
-
Senegal lodge appeal to Court of Arbitration for Sport over AFCON final decision
-
South Africa seal T20 series win in New Zealand
-
Study links major polluters to big climate damages bill
-
Ex-Google chief Matt Brittin made new BBC director-general
-
Iran likely behind attacks sowing fear among Europe's Jews: experts
-
'Relieved' McGrath claims career first crystal globe in slalom
-
US ski star Shiffrin wins overall World Cup title for sixth time
-
Trump names tech titans to science advisory council
-
Mideast war sparks long queues at Kinshasa petrol stations
-
US TV star details 'agony' over mother's disappearance
-
Tehran receives US plan to end Mideast war, as Iran fires at US carrier
-
Aviation, tourism, agriculture... the economic sectors hit by the war
-
Iran fires at US carrier as backchannel diplomacy aims to end war
-
Salah's long goodbye brings curtain down on golden era for Liverpool
-
Monaco: city of vice and a few virtues
-
AI making cyber attacks costlier and more effective: Munich Re
-
Defying Israeli bombs, Lebanese hold out in southern city of Tyre
-
War-linked power crunch pushes Sri Lanka to four-day week
-
Hungary says will phase out gas deliveries to Ukraine
-
Oil prices tumble, stocks rally on Mideast peace hopes
-
IEA chief says 'ready' to release more oil reserves if needed
-
Maybach: Between Glory and a Turning Point
-
Iran, Israel trade strikes as diplomats work behind the scenes
-
German business morale falls as war puts recovery on ice: survey
-
Labubu maker Pop Mart's shares fall 23% despite surging earnings
-
ECB won't be 'paralysed' in face of energy shock: Lagarde
-
Iran hits targets across Middle East after Trump signals talks progress
-
McEvoy says best is to come after breaking long-standing swim record
-
Japan PM asks IEA to prepare additional 'coordinated release' of oil
-
Goat vs gecko: A tiny Caribbean island faces wildlife showdown
-
Japan PM asks IEA chief to prepare additional 'coordinated release' of oil
-
Hungary's hard-pressed LGBTQ people say Orban exit is only half battle
-
Belarus leader visits North Korea for first time
-
'No heavier burden': the decades-long search for Kosovo war missing
-
Exotic pet trade thrives in China despite welfare concerns
-
Iran fires missile salvo after Trump signals progress in talks
-
BTS concert drew 18.4 million viewers, says Netflix
-
OSCE's 'chaotic' Ukraine evacuation put staff at risk: leaked report
-
Top WTO official sounds fertiliser warning over Middle East war
-
France and Brazil weigh up World Cup prospects in glamour friendly
-
Italy hoping to end World Cup pain as play-offs loom
-
Dirty diapers born again in Japan recycling breakthrough
-
Verstappen's Japan GP win streak under threat as Mercedes dominate
-
Crude tumbles, stocks rally on hopes for Iran war de-escalation
-
Sinner powers past Michelsen to reach Miami quarter-finals
-
Gauff outlasts Bencic to reach Miami semi-finals
-
'Hero' Australian dog who saved 100 koalas retires
US Supreme Court rejects bid to restrict abortion pill
The US Supreme Court on Thursday rejected a bid to restrict an abortion pill widely used in the United States to terminate pregnancies.
The court, in a unanimous opinion, said the anti-abortion groups and physicians challenging the medication, mifepristone, lacked the legal standing to bring the case.
Abortion rights are one of the key issues in the November election and the administration of Democratic President Joe Biden had urged the court to maintain access to the drug, which was approved by the Food and Drug Administration (FDA) in 2000. His opponent Donald Trump leads a Republican Party broadly favoring blocks to abortion access.
The mifepristone case was the first significant abortion case heard by the conservative-dominated Supreme Court since it overturned the previously long-held constitutional right to abortion two years ago.
"We recognize that many citizens, including the plaintiff doctors here, have sincere concerns about and objections to others using mifepristone and obtaining abortions," said Justice Brett Kavanaugh, who wrote the 9-0 opinion.
"But citizens and doctors do not have standing to sue simply because others are allowed to engage in certain activities," Kavanaugh said. "The plaintiffs lack standing to challenge FDA's actions."
The conservative justice said the federal courts were "the wrong forum for addressing the plaintiffs' concerns about FDA's actions" and they could present their objections through regulatory procedures or through the "political and electoral processes."
Abortion opponents have been seeking to restrict nationwide access to the pill, claiming it is unsafe and that anti-abortion doctors were being forced to violate their conscience by intervening on patients who suffered complications after using it.
A conservative US district court judge in Texas, who was appointed during Trump's presidency, issued a ruling last year that would have banned mifepristone.
An appeals court overturned the outright ban because the statute of limitations on challenging the FDA's approval had expired, but restricted access to the drug.
The appeals court reduced the period during which mifepristone can be used from 10 weeks of pregnancy to seven weeks, blocked it from being delivered by mail, and required the pill to be prescribed and administered by a doctor.
The Supreme Court ruling lifts those restrictions.
Medication abortion accounted for 63 percent of the abortions in the country last year, up from 53 percent in 2020, according to the Guttmacher Institute.
Some 20 states have banned or restricted abortion since the Supreme Court in June 2022 overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century.
Polls show a majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure or ban it outright.
N.Shalabi--SF-PST